Holger Semsch is a senior advisor to global life sciences companies by providing expertise in the launch and commercialization phase. He is heading the European LSH consulting team and is spearheading HCL’s patient engagement efforts.
With more than a decade of industry experience, he has specialized in the areas of patient engagement & market intelligence. He has led numerous global projects across various therapeutic areas for the Top pharmaceutical companies and was involved in award-winning innovation initiatives with customer organizations, e.g. the Alexa Diabetes challenge by AWS/Merck & Co.
Prior to joining HCL in 2014, Holger held various sales and operation leadership roles and played an essential part in growing a start-up till acquisition by Veeva Systems.
He studied psychology at the University of Technology Dresden, Germany and management & organizations at the UWA Business School in Perth, Australia.